Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 201–300 of 999
Syed, I., Jayaram, B., Subasinghe, W., & Kowluru, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.006 · Cited by 79
Chronic Resveratrol Treatment Protects Pancreatic Islets against Oxidative Stress in db/db Mice
Lee, Y. E., Kim, J.-W., Lee, E. M., Ahn, Y., Song, K., Yoon, K., Kim, H.-W., Park, C.-W., Li, G., Liu, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050412 · Cited by 86
Luo, X., Li, R., & Yan, L. (2015) · Journal of Diabetes Research · doi:10.1155/2015/512618 · Cited by 90
Impaired β-cell-β-cell coupling mediated by Cx36 gap junctions in prediabetic mice
Carvalho, C. P. F., Oliveira, R. B., Britan, A., Santos-Silva, J. C., Boschero, A. C., Meda, P., & Collares-Buzato, C. B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2011 · Cited by 77
Kowluru, A., & Kowluru, R. A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.017 · Cited by 77
“chronic exposure of cells to elevated glucose [glucotoxicity], fatty acids [lipotoxicity] or both [glucolipotoxicity] leads to impairment of cellular dysfunction and demise [2,3].”
Ishida, E., Kim-Muller, J. Y., & Accili, D. (2017) · Diabetes · doi:10.2337/db16-1213 · Cited by 83
“Various mechanisms of b-cell failure have been proposed, including glucolipotoxicity (5), oxidative stress (6,7), endoplasmic reticulum stress (8,9), apoptosis (10,11), or inflammation (6,12).”
BackgroundSarre, A., Gabrielli, J., Vial, G., Leverve, X. M., & Assimacopoulos‐Jeannet, F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.437 · Cited by 76
Suppression of KATP channel activity protects murine pancreatic β cells against oxidative stress
Gier, B., Krippeit-Drews, P., Sheiko, T., Aguilar-Bryan, L., Bryan, J., Düfer, M., & Drews, G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38817 · Cited by 75
“In addition to the increase in blood glucose concentration, lipid metabolism is altered in type 2 diabetes, and both parameters, termed glucolipotoxicity, are factors in the development of the disease (1).”
BackgroundKowluru, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.013 · Cited by 76
Pearson, G. L., Chai, B., Vozheiko, T. D., Liu, X., Kandarpa, M., Piper, R. C., & Soleimanpour, S. A. (2017) · Diabetes · doi:10.2337/db17-0321 · Cited by 77
Pascoe, J., Hollern, D., Stamateris, R., Abbasi, M., Romano, L. C., Zou, B., O’Donnell, C. P., Garcia-Ocana, A., & Alonso, L. C. (2012) · Diabetes · doi:10.2337/db11-0991 · Cited by 74
Prévost, G., Arabo, A., Jian, L., Quelennec, E., Cartier, D., Hassan, S., Falluel‐Morel, A., Tanguy, Y., Gargani, S., Lihrmann, I., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1167 · Cited by 88
Solomon, T. P. J., Haus, J. M., Marchetti, C. M., Stanley, W. C., & Kirwan, J. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00220.2009 · Cited by 73
Mitochondrial dynamics and morphology in beta-cells
Stiles, L., & Shirihai, O. S. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.004 · Cited by 74
Perfluorooctanoic acid induces oxidative damage and mitochondrial dysfunction in pancreatic β-cells
Suh, K. S., Choi, E. M., Kim, Y. J., Hong, S. M., Park, S. Y., Rhee, S. Y., Oh, S., Kim, S. W., Pak, Y. K., Choe, W., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6452 · Cited by 70
“Pancreatic β ‑cells are particularly sensitive to oxidative damage; therefore mitochondrial oxidative damage may underlie the marked loss of β ‑cell function (16).”
Foods for the prevention of diabetes: how do they work?
Thomas, T., & Pfeiffer, A. F. H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1229 · Cited by 73
“Another emerging hypothesis is that fatty acids, under the permissive effect of elevated glucose, can exert damaging or toxic effects on β-cells, a concept known as glucolipotoxicity [26].”
BackgroundMisfolded Proinsulin Affects Bystander Proinsulin in Neonatal Diabetes
Hodish, I., Liu, M. R., Rajpal, G., Larkin, D. D., Holz, R. W., Adams, A. M., Liu, L., & Arvan, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038042 · Cited by 81
Saadeh, M., Ferrante, T. C., Kane, A., Shirihai, O. S., Corkey, B. E., & Deeney, J. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030200 · Cited by 77
Liu, J., Chen, Z., Zhang, Y., Zhang, M., Zhu, X., Fan, Y., Shi, S., Zen, K., & Liu, Z. (2013) · Diabetes · doi:10.2337/db13-0251 · Cited by 77
A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death
Baldwin, A. C., Green, C. D., Olson, L. K., Moxley, M. A., & Corbett, J. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00519.2011 · Cited by 82
Malmgren, S., Spégel, P., Danielsson, A. P. H., Nagorny, C. L., Andersson, L. E., Nitert, M. D., Ridderstråle, M., Mulder, H., & Ling, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422527 · Cited by 71
Chrysoeriol and other polyphenols from Tecoma stans with lipase inhibitory activity
Ramírez, G., Zamilpa, A., Zavala-Sánchez, M. Á., Perez, J. C., Morales-Ferra, D. L., & Tortoriello, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.03.014 · Cited by 79
Solomon, T. P. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00896 · Cited by 70
Moon, J. S., Karunakaran, U., Elumalai, S., Lee, I., Lee, H. W., Kim, Y., & Won, K. C. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.09.001 · Cited by 75
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Cadavez, L., Montané, J., Alcarraz‐Vizán, G., Visa, M., Laia, V.-F., Servitja, J., & Novials, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101797 · Cited by 78
“Treatment with high glucose and palmitic acid diminished insulin secretion in hIAPP-INS1E cells, confirming a glucolipotoxic effect [47].”
BackgroundGlucotoxicity and pancreatic proteomics
Brunner, Y., Schvartz, D., Priego‐Capote, F., Couté, Y., & Sanchez, J. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.10.002 · Cited by 74
Physiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
“Over time, β-cell function and/or β-cell mass diminishes, leading to more severe hyperglycemia; a feed-forward cycle of disease pathogenesis (116).”
van Asseldonk, E. J. P., van Poppel, P. C. M., Ballak, D. B., Stienstra, R., Netea, M. G., & Tack, C. J. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.06.003 · Cited by 72
Costes, S., Bertrand, G., & Ravier, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105303 · Cited by 81
Shaked, M., Ketzinel‐Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028804 · Cited by 77
“diabetes, a process called glucolipotoxicity [2].”
Afrin, R., Arumugam, S., Soetikno, V., Thandavarayan, R. A., Pitchaimani, V., Karuppagounder, V., Sreedhar, R., Harima, M., Suzuki, H., Miyashita, S., et al. (2015) · Free Radical Research · doi:10.3109/10715762.2014.999674 · Cited by 74
Gosmain, Y., Cheyssac, C., Heddad Masson, M., Dibner, C., & Philippe, J. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01445.x · Cited by 68
“It is well known that the factors that acutely stimulate insulin secretion, such as glucose and free fatty acids, actually inhibit insulin secretion and insulin biosynthesis, when chronically elevated [39].”
BackgroundGlucolipotoxicity of the pancreatic β-cell: myth or reality?
Poitout, V. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360901 · Cited by 68
“Prolonged exposure of isolated islets or insulin-secreting cells to simultaneously elevated levels of fatty acids and glucose leads to inhibition of glucose-induced insulin secretion, impairment of insulin gene expression, and induction of cell death by apoptosis (reviewed in [5]).”
Self-citationHuang, Q., Liu, Z., Yang, Y., Yang, Y., Huang, T., Hong, Y. C., Zhang, J., Chen, Q., Zhao, T., Xiao, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202300880 · Cited by 73
Maiztegui, B., Borelli, M. I., Madrid, V., Zotto, H. H. D., Raschia, M. A., Francini, F., Massa, M. L., Flores, L. E., Rebolledo, O. R., & Gagliardino, J. J. (2010) · Clinical Science · doi:10.1042/cs20100372 · Cited by 73
Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
Saberi, M., Bjelica, D., Schenk, S., Imamura, T., Bandyopadhyay, G. K., Li, P., Jadhar, V., Vargeese, C., Wang, W., Bowman, K., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2009 · Cited by 69
“It is well known that hyperglycemia and elevated fatty acid levels can cause insulin resistance (27); therefore, the normalization of these factors in the TORC2 knockdown mice would be expected to secondarily improve peripheral insulin sensitivity.”
Verkest, K. R., Rand, J. S., Fleeman, L. M., & Morton, J. M. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.10.002 · Cited by 92
Amo-Shiinoki, K., Tanabe, K., Hoshii, Y., Matsui, H., Harano, R., Fukuda, T., Takeuchi, T., Bouchi, R., Takagi, T., Hatanaka, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143791 · Cited by 73
“Although it is accepted that increased apoptosis plays a role in declining β cell function and mass over time (5–8), an increase in apoptosis alone is insufficient to explain the β cell deficit in type 2 diabetes (9, 10).”
Liang, Y., Zhang, Z., Tu, J., Wang, Z., Gao, X., Deng, K., El-Samahy, M. A., You, P., Fan, Y., & Wang, F. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02596 · Cited by 67
Muhammed, S. J., Lundquist, I., & Salehi, A. A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01632.x · Cited by 72
Emerging Concepts in the Pathophysiology of Type 2 Diabetes Mellitus
Surampudi, P. N., John‐Kalarickal, J., & Fonseca, V. A. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20113 · Cited by 91
Saisho, Y. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.132 · Cited by 71
Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health
Tong, X., Dai, C., Walker, J. T., Nair, G. G., Kennedy, A. J., Carr, R. M., Hebrok, M., Powers, A. C., & Stein, R. W. (2019) · Diabetes · doi:10.2337/db19-0281 · Cited by 72
Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
Wang, H., Wang, L., Zhao, C.-Y., & Lan, H. Y. (2022) · Biomolecules · doi:10.3390/biom12030373 · Cited by 74
In vivo and in vitro antidiabetic effects of citrus flavonoids; a study on the mechanism of action
Mahmoud, A. M., Ahmed, O. M., Ashour, M. B., & Abdel‐Moneim, A. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-014-0268-x · Cited by 70
“Glucotoxicity eventually leads to progressive β cell dysfunction, impaired insulin gene transcription, and permanent β cell loss due to apoptosis, ensuing in a vicious cycle with exasperation of the hyperglycemia [2].”
Endoplasmic Reticulum Stress in the β-Cell Pathogenesis of Type 2 Diabetes
Back, S. H., Kang, S.-W., Han, J., & Chung, H.-T. (2012) · Experimental Diabetes Research · doi:10.1155/2012/618396 · Cited by 65
Keane, D., Takahashi, H., Dhayal, S., Morgan, N. G., Curi, R., & Newsholme, P. (2010) · Clinical Science · doi:10.1042/cs20100282 · Cited by 66
Fate of the beta-cell in the pathophysiology of type 2 diabetes
Campbell, R. K. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09076 · Cited by 68
Yang, Y., Chang, B. H., & Chan, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201398 · Cited by 71
“As hyperglycaemia per se has been reported to downregulate insulin expression as well as stimulate beta cell apoptosis (Olson et al, 1993; Poitout & Robertson, 2002, 2008; Robertson et al, 2004), we used two strategies to circumvent these effects of hyperglycaemia in the TAM-treated Glis3 fl / fl /…”
Hanchang, W., Khamchan, A., Wongmanee, N., & Seedadee, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116858 · Cited by 71
Wu, T., Shao, Y., Li, X., Wu, T., Yu, L. K., Liang, J. H., Zhang, Y., Wang, J., Sun, T., Zhu, Y., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2200625 · Cited by 74
Beta-cell compensation and gestational diabetes
Usman, T. O., Chhetri, G., Yeh, H., & Dong, H. H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105405 · Cited by 83
“Chronic oxidative stress is thought to be an underlying cause of glu-colipotoxicity for β -cell dysfunction in type 2 diabetes (65 – 67).”
BackgroundNoordeen, N. A., Khera, T. K., Sun, G., Longbottom, E. R., Pullen, T. J., Xavier, G. D. S., Rutter, G. A., & Leclerc, I. (2009) · Diabetes · doi:10.2337/db08-0868 · Cited by 71
“This may further exacerbate the effects of elevated nuclear levels of ChREBP to drive lipogenic gene expression and hence, potentially, contribute to “gluco-lipotoxicity” (1,33) under these conditions.”
BackgroundImamura, F., Sharp, S. J., Koulman, A., Schulze, M. B., Kröger, J., Griffin, J. L., Huerta, J. M., Guevara, M., Sluijs, I., Agudo, A., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002409 · Cited by 75
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
Bellini, L., Campaña, M. B., Mahfouz, R., Carlier, A., Véret, J., Magnan, C., Hajduch, É., & Stunff, H. L. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1028359 · Cited by 68
“It has also been shown that de novo ceramide synthesis pathway is implicated on pancreatic b-cell apoptosis [8,53].”
BackgroundInfluentialUnsaturated fatty acids as cytoprotective agents in the pancreatic β-cell
Morgan, N. G., & Dhayal, S. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.018 · Cited by 73
Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B. P., McCall, A. L., & Brayman, K. L. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0006 · Cited by 67
Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes
Kassab, A., & Piwowar, A. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.020 · Cited by 74
A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes
Khin, P. P., Lee, J., & Jun, H. (2021) · Nutrients · doi:10.3390/nu13051593 · Cited by 70
Targeting pancreatic β cells for diabetes treatment
Jain, C., Ansarullah, M., Bilekova, S., & Lickert, H. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00618-5 · Cited by 71
Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction
Wu, L., Zhou, L., Lü, Y., Zhang, J., Jian, F., Liu, Y., Li, F., Li, W., Wang, X. Q., & Guo, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.009 · Cited by 68
Hong, K.-H., Xu, G., Grayson, T. B., & Shalev, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698365 · Cited by 67
“Lipotoxicity and especially combined gluco-lipotoxicity is another key factor contributing to -cell dysfunction and death especially in the context of type 2 diabetes (9).”
BackgroundFu, J., Cui, Q., Yang, B., Hou, Y., Wang, H., Xu, Y., Wang, D., Zhang, Q., & Pi, J. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.12.016 · Cited by 66
Jones, H. B., Nugent, D., & Jenkins, R. P. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00713.x · Cited by 64
“…adverse influences, mainly of hyperglycaemia and hyperlipidaemia have been recognised to affect b-cell metabolic pathways and islet functional integrity both directly and indirectly (Stefan et al. 1982; Clark et al. 1988; Zhou et al. 2000; Listenberger et al. 2003; Poitout & Robertson 2008).”
Obesity and Insulin Resistance: An Abridged Molecular Correlation
Mukherjee, B., Hossain, C. M., Mondal, L., Paul, P., & Ghosh, M. K. (2013) · Lipid Insights · doi:10.4137/lpi.s10805 · Cited by 79
An examination of β‐cell function measures and their potential use for estimating β‐cell mass
Kahn, S. E., Carr, D. B., Faulenbach, M. V., & Utzschneider, K. M. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00945.x · Cited by 60
Jesinkey, S. R., Madiraju, A. K., Alves, T. C., Yarborough, O. H., Cardone, R. L., Zhao, X., Parsaei, Y., Nasiri, A. R., Butrico, G., Liu, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.058 · Cited by 60
Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
Lee, J.-H., Mellado‐Gil, J. M., Bahn, Y. J., Pathy, S. M., Zhang, Y. E., & Rane, S. G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2365-8 · Cited by 67
Qian, J., Yeh, B., Rakshit, K., Colwell, C. S., & Matveyenko, A. V. (2015) · Endocrinology · doi:10.1210/en.2015-1516 · Cited by 64
Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 70
Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
Page, K. A., & Reisman, T. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0363-2 · Cited by 64
Fontés, G., Semache, M., Hagman, D. K., Tremblay, C., Shah, R., Rhodes, C. J., Rutter, J., & Poitout, V. (2009) · Diabetes · doi:10.2337/db08-0579 · Cited by 59
“he glucolipotoxicity hypothesis posits that abnormalities in lipid metabolism, in conjunction with chronic hyperglycemia, contribute to the deterioration of -cell function in type 2 diabetes ( 1 ,2).”
BackgroundSelf-citationNtimbane, T., Mailhot, G., Spahis, S., RABASA-LHORET, R. P. R., Kleme, M.-L., Melloul, D., Brochiero, E., Berthiaume, Y., & Levy, E. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00333.2015 · Cited by 69
Brain control of blood glucose levels: implications for the pathogenesis of type 2 diabetes
Alonge, K. M., D’Alessio, D. A., & Schwartz, M. W. (2020) · Diabetologia · doi:10.1007/s00125-020-05293-3 · Cited by 70
CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
Karunakaran, U., Elumalai, S., Moon, J. S., & Won, K. C. (2021) · Cells · doi:10.3390/cells10071833 · Cited by 66
A review on potential anti-diabetic mechanisms of chitosan and its derivatives
Priyanka, D., Prashanth, K. V. H., & Tharanathan, R. N. (2022) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2022.100188 · Cited by 73
β-cell neogenesis: A rising star to rescue diabetes mellitus
Niu, F., Liu, W., Ren, Y., Tian, Y., Shi, W., Li, M., Li, Y., Xiong, Y., & Lü, Q. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.10.008 · Cited by 77
“…apoptosis [13,14], (2) b -cells dysfunction: a chronic load on b -cells results in normal b -cells failing to produce insulin against glucose [15,16], and (3) b -cell identity loss (dedifferentiation and trans - differentiation of b -cells): dedifferentiation of islet b -cells is defined as the…”
BackgroundIshikawa, K., Tsunekawa, S., Ikeniwa, M., Izumoto, T., Iida, A., Ogata, H., Uenishi, E., Seino, Y., Ozaki, N., Sugimura, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115350 · Cited by 58
“In addition, glucotoxicity reportedly damages the DNA binding affinity of PDX-1 [27], implying that DNAmethylation is involved.”
BackgroundModulating GPR40: therapeutic promise and potential in diabetes
Poitout, V., & Lin, D. C.-H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.003 · Cited by 62
Self-citationPathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis
Al‐Khawaga, S., Memon, B., Butler, A. E., Taheri, S., Abou‐Samra, A., & Abdelalim, E. M. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12349 · Cited by 64
“These toxic oligomers compromise β-cell function and cause a progressive reduction of the pancreatic β-cell mass by inducing β-cell apoptosis (Butler et al., 2003; Prentki & Nolan, 2006; Poitout & Robertson, 2008; Costes et al., 2013).”
BackgroundNagao, M., Esguerra, J. L. S., Asai, A., Ofori, J. K., Edlund, A., Wendt, A., Sugihara, H., Wollheim, C. B., Oikawa, S., & Eliasson, L. (2020) · Diabetes · doi:10.2337/db19-0944 · Cited by 61
“A number of in vitro studies have identified mechanisms involved in impaired insulin secretion by chronic fatty acid (FA) elevation (7,8), including those affecting exocytosis (9).”
BackgroundMolecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction
Benito‐Vicente, A., Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Uribe, K. B., & Martín, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.013 · Cited by 65
Frizzell, N., Thomas, S. A., Carson, J. A., & Baynes, J. W. (2012) · Biochemical Journal · doi:10.1042/bj20112142 · Cited by 58
What Regulates Basal Insulin Secretion and Causes Hyperinsulinemia?
Corkey, B. E., Deeney, J. T., & Merrins, M. J. (2021) · Diabetes · doi:10.2337/dbi21-0009 · Cited by 60
Ramos, J. S., Dalleck, L. C., Borrani, F., Mallard, A. R., Clark, B., Keating, S. E., Fassett, R. G., & Coombes, J. S. (2016) · Diabetologia · doi:10.1007/s00125-016-4064-7 · Cited by 65
“The continuous demand for insulin in the face of IR, coupled with the glucolipotoxic environment associated with MetS [3], adversely affects the quality of insulin produced and secreted by the pancreatic beta cells [4, 5].”
BackgroundZheng, S., Zhao, M., Younan, R., Wu, Y., & Jie-ren, Y. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.031 · Cited by 57
The role of insulin signaling in the development of β-cell dysfunction and diabetes
Wang, Q., & Jin, T. (2009) · Islets · doi:10.4161/isl.1.2.9263 · Cited by 64
Somesh, B. P., Verma, M. K., Sadasivuni, M. K., Oommen, A. M., Biswas, S., Shilpa, P. C., Reddy, A. K., Yateesh, A. N., Pallavi, P. M., Siddaraju, N., et al. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-31 · Cited by 61
“To evaluate the effect of high glucose and fatty acid concentrations on insulin secretion, we incubated rat pancreatic islets as mentzioned above for 72 h (chronic glucolipotoxic conditions that mimic diabetic pathology [26]); untreated islets were used as control.”
BackgroundMethodAnderson, R. L., Ternes, S. B., Strand, K. A., & Rowling, M. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2010 · Cited by 60
“failure via β cell lipotoxicity and apoptosis (159).”
BackgroundRapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
Liu, Y., Prentice, K. J., Eversley, J. A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J. B., Wei, D. W., Cox, B., Dai, F. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.079 · Cited by 59
“It has been suggested that chronic factors, including glucolipotoxicity, inflammation, endoplasmic reticulum (ER) stress, and/or oxidative stress may collectively exhaust the beta cell compensatory capacity, reducing beta cell mass and insulin secretion over time until compensation is no longer feasible (Abdul-Ghani e…”
BackgroundScoville, D. W., Kang, H. S., & Jetten, A. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107632 · Cited by 60
Spinnler, R., Gorski, T., Stolz, K., Schuster, S., Garten, A., Beck-Sickinger, A. G., Engelse, M. A., de Koning, E. J. P., Körner, A., Kiess, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054106 · Cited by 55
Wang, X., Zhao, X., Zhou, R., Gu, Y., Zhu, X., Tang, Z., Yuan, X., Chen, W., Zhang, R., Chen, Q., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12834 · Cited by 61
Plötz, T., von Hanstein, A. S., Krümmel, B., Laporte, A., Mehmeti, I., & Lenzen, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.08.001 · Cited by 62
Cerf, M. E. (2020) · Metabolites · doi:10.3390/metabo10110452 · Cited by 65
Rashid, M. A., Lee, S., Tak, E., Lee, J., Choi, T. G., Lee, J.-W., Kim, J. B., Youn, J. H., Kang, I., Ha, J., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.015 · Cited by 58
Role of the Saturated Nonesterified Fatty Acid Palmitate in Beta Cell Dysfunction
Maris, M., Robert, S., Waelkens, E., Derua, R., Hernangómez, M., D’Hertog, W., Cnop, M., Mathieu, C., & Overbergh, L. (2012) · Journal of Proteome Research · doi:10.1021/pr300596g · Cited by 60
Shaked, M., Ketzinel‐Gilad, M., Ariav, Y., Cerasi, E., Kaiser, Ν., & Leibowitz, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1274-2 · Cited by 67
PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice
Iglesias, J., Barg, S., Vallois, D., Lahiri, S., Roger, C., Yessoufou, A., Pradevand, S., McDonald, A., Bonal, C., Reimann, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci42127 · Cited by 71
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.